相关实验视频

Updated: Apr 12, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

一种定制的水溶性基宏环多核Gd³⁺ - - 合性偏磁多模式对比剂,用于以线粒体为目标的光成像,与MRI集成

Samiran Kar¹, Rabi Sankar Das¹, Tapas Bera¹

¹Department of Chemistry, Organic Chemistry Section, Jadavpur University, Kolkata 700032, India.

Analytical chemistry

|October 16, 2025

概括

研究人员开发了一种新的基于的多模式对比剂,用于先进的生物医学成像. 这种药物结合了光和磁共振成像功能,用于增强细胞诊断.

科学领域:

生物医学工程生物医学工程
分子成像学分子成像学
纳米技术纳米技术

背景情况:

多式成像探头集成了光生物标志物和磁共振 (MR) 对比剂,以获得协同的诊断信息.
开发有针对性的探针对于推进生物医学诊断和了解细胞过程至关重要.

研究的目的:

为了合成和描述一种新的基于的多模式对比剂,用于细胞器官向成像.
为了评估该剂在光显微镜和活细胞MRI中的性能.

主要方法:

采用Fmoc固相合成方法的定制合成.
一种半氨酸 (HCy) 光染料与一个宏环多核三-Lys ((DOTA-Gd3+) MRI对比剂的整合.
磁性特性和放松性的表征 (r1).

主要成果:

成功合成了HCy-Lys (DOTA-Gd3+) -Lys (DOTA-Gd3+) -Lys (DOTA-Gd3+) -Gly的代理物.
证明了高的纵向放松性 (r1 = 7.65 mM-1 s-1) 和相当大的磁矩.
在活细胞线粒体向的共聚焦显微镜,3D成像,3D实时监测和多色成像与T1加权MRI的有效应用.

结论:

开发的基于的多模式对比剂提供了增强的MRI对比度和稳定的Gd3+化.
它的生物相容性,水溶性和多式成像能力使其成为活细胞线粒体向诊断的有希望的工具.
这种药物超越了单模成像的局限性,为先进的生物医学诊断铺平了道路.

更多相关视频

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications

Published on: April 28, 2015

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...